Market closedNon-fractional
TG Therapeutics/TGTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About TG Therapeutics
Ticker
TGTX
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Morrisville, United States
Employees
284
Website
www.tgtherapeutics.com
TG Therapeutics Metrics
BasicAdvanced
$2.9B
Market cap
71.54
P/E ratio
$0.28
EPS
2.32
Beta
-
Dividend rate
Price and volume
Market cap
$2.9B
Beta
2.32
Financial strength
Current ratio
3.617
Quick ratio
2.756
Long term debt to equity
68.882
Total debt to equity
69.253
Interest coverage (TTM)
4.01%
Management effectiveness
Return on assets (TTM)
10.59%
Return on equity (TTM)
43.93%
Valuation
Price to earnings (TTM)
71.535
Price to revenue (TTM)
9.905
Price to book
17.67
Price to tangible book (TTM)
17.76
Price to free cash flow (TTM)
141.294
Growth
Revenue change (TTM)
3,275.33%
Earnings per share change (TTM)
-122.68%
3-year revenue growth (CAGR)
583.28%
3-year earnings per share growth (CAGR)
-52.55%
What the Analysts think about TG Therapeutics
Analyst Ratings
Majority rating from 9 analysts.
TG Therapeutics Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$63M
44.42%
Net income
-$11M
-25.69%
Profit margin
-16.87%
-48.57%
TG Therapeutics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.34
$0.73
-$0.10
-$0.07
-
Expected
-$0.25
$0.12
-$0.10
-$0.04
-$0.05
Surprise
36.68%
530.87%
-4.11%
96.00%
-
TG Therapeutics News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for TG Therapeutics stock?
TG Therapeutics (TGTX) has a market cap of $2.9B as of July 27, 2024.
What is the P/E ratio for TG Therapeutics stock?
The price to earnings (P/E) ratio for TG Therapeutics (TGTX) stock is 71.54 as of July 27, 2024.
Does TG Therapeutics stock pay dividends?
No, TG Therapeutics (TGTX) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next TG Therapeutics dividend payment date?
TG Therapeutics (TGTX) stock does not pay dividends to its shareholders.
What is the beta indicator for TG Therapeutics?
TG Therapeutics (TGTX) has a beta rating of 2.32. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell TG Therapeutics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.